The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going in 2026?

Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday's stock market.

Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.

This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR ...

This clinical-stage biotech develops therapies for serious immunological diseases, with a focus on late-stage biologic candidates.

Azitra Inc. has secured up to $31.4 million in private financing as the company works to regain compliance with stock ...

Robertet has invested in Aethera Biotech to boost its expertise in biotech and grow its health and beauty division. The ...

Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.